Searle Cytotec
Executive Summary
"Special considerations" boxed warning added to misoprostol labeling in order to strengthen contraindication in pregnancy. Labeling has also been updated to include reports of serious adverse events associated with use of Cytotec in pregnant women (1"The Pink Sheet" Aug. 28, p. 14)
You may also be interested in...
Cytotec Relabeling Adds Labor Section; Mifeprex “Dear Doctor” Letter Sent
FDA is requiring Pharmacia to re-label Cytotec (misoprostol) to reflect use with Danco's Mifeprex without explicitly addressing the abortifacient regimen
Cytotec Relabeling Adds Labor Section; Mifeprex “Dear Doctor” Letter Sent
FDA is requiring Pharmacia to re-label Cytotec (misoprostol) to reflect use with Danco's Mifeprex without explicitly addressing the abortifacient regimen
Searle Cytotec Pregnancy Reminder Issued As RU-486 Action Nears
Searle issued a reminder Aug. 23 that its gastric ulcer treatment Cytotec (misoprostol) is contraindicated for use in pregnant women, about a month before FDA action is expected on the pending NDA for mifepristone.